AINDEX
Markets

INVO Fertility, Inc. (IVF)

IVFNASDAQ-CMMedical/Dental Instruments

$2.40

-0.2200 (-8.40%) today

At the close, Nov 16, 4:00 PM ET. After hours $2.39 -0.42%

-8.40% 1D
Market cap
$2.76m
P/E
–
EPS, last 4 quarters
–
Dividend yield
–
Day range
$2.34 to $2.74
52-week range
$1.59 to $91.60
Average volume
–
Previous close
$2.62

Earnings

Next report

Financials

QuarterSep 2025Dec 2025Mar 2026Jun 2026
Revenue$1.76m$1.58m$2.02m$2.17m
Gross profit$629.0k$537.0k$728.0k$763.0k
Operating income-$1.64m-$1.41m-$1.59m-$1.29m
Net income-$4.31m$2.01m-$5.54m$889.0k

Last four quarters: revenue $7.53m, margin -92.3%, free cash flow –

News

8 latest

The company

We are a healthcare services fertility company dedicated to expanding access to assisted reproductive technology ('ART') care to patients in need. Our principal commercial strategy is focused on building, acquiring, and operating fertility clinics and related businesses and technologies. Our acquisition strategy focuses on U.S.-based, profitable fertility clinics. Our clinics offer a variety of fertility services including in vitro fertilization ('IVF') and the intravaginal culture ('IVC') procedure enabled by INVOcell. We have four operational fertility clinics in the United States. We also continue to engage in the sale and distribution of INVOcell to third-party owned and operated fertility clinics. INVOcell is a proprietary and revolutionary medical device, and the first to allow fertilization and early embryo development to take place in vivo within the woman's body.

Sector
Health Care
Industry
Medical/Dental Instruments
Exchange
NASDAQ-CM
Region
North America

Often looked at with it

Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.